Korro Bio, Inc. (KRRO)
(Delayed Data from NSDQ)
$52.32 USD
-1.69 (-3.13%)
Updated May 8, 2024 04:00 PM ET
After-Market: $51.86 -0.46 (-0.88%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for Korro Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -81.17 | -81.58 | -84.69 | -26.51 | -18.75 |
Depreciation/Amortization & Depletion | 3.55 | 2.77 | 2.78 | 1.15 | 0.81 |
Net Change from Assets/Liabilities | 4.28 | -2.02 | -17.33 | -30.24 | 48.65 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.06 | 22.60 | 23.18 | 10.42 | 3.50 |
Net Cash From Operating Activities | -67.28 | -58.24 | -76.06 | -45.19 | 34.22 |
Property & Equipment | -7.84 | 0.02 | -2.91 | -6.67 | -1.06 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 19.00 | 31.12 | -63.21 | 17.07 | -17.20 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 11.16 | 31.13 | -66.13 | 10.40 | -18.26 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 163.41 | 0.26 | 1.36 | 1.55 | 142.02 |
Issuance (Repayment) of Debt | 0.00 | -0.83 | 0.00 | 15.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 24.35 | 0.00 | 0.00 | 40.14 | 0.00 |
Net Cash from Financing Activities | 187.76 | -0.58 | 1.36 | 56.69 | 142.02 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 131.64 | -27.68 | -140.83 | 21.90 | 157.97 |
Cash at Beginning of Period | 41.48 | 81.33 | 222.16 | 200.26 | 42.19 |
Cash at End of Period | 173.12 | 53.65 | 81.33 | 222.16 | 200.16 |
Diluted Net EPS | -53.08 | -116.50 | -123.50 | -41.00 | -114.50 |
Fiscal Year End for Korro Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -81.17 | -41.95 | -30.34 | -19.54 |
Depreciation/Amortization & Depletion | NA | 3.55 | 1.88 | 1.49 | 1.00 |
Net Change from Assets/Liabilities | NA | 4.28 | 1.78 | -1.08 | 0.46 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 6.06 | 10.94 | 7.37 | 3.95 |
Net Cash From Operating Activities | NA | -67.28 | -27.36 | -22.56 | -14.13 |
Property & Equipment | NA | -7.84 | -0.04 | -0.08 | -0.09 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 19.00 | 31.57 | 24.79 | 5.59 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 11.16 | 31.53 | 24.71 | 5.50 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 163.41 | 0.03 | 0.03 | 0.03 |
Issuance (Repayment) of Debt | NA | 0.00 | -14.17 | -14.17 | -2.50 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 24.35 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 187.76 | -14.13 | -14.14 | -2.47 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 131.64 | -9.96 | -11.98 | -11.10 |
Cash at Beginning of Period | NA | 41.48 | 53.65 | 53.65 | 53.65 |
Cash at End of Period | NA | 173.12 | 43.69 | 41.67 | 42.55 |
Diluted Net EPS | NA | 4.92 | -15.50 | -15.00 | -27.50 |